For: | Yap DYH, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol 2014; 20(2): 468-474 [PMID: 24574715 DOI: 10.3748/wjg.v20.i2.468] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/468.htm |
Number | Citing Articles |
1 |
Mohammed Rafique Moosa, Jonathan David Maree, Maxwell T. Chirehwa, Solomon R. Benatar, Jaap A. Joles. Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country. PLOS ONE 2016; 11(10): e0164201 doi: 10.1371/journal.pone.0164201
|
2 |
Charat Thongprayoon, Wisit Kaewput, Konika Sharma, Karn Wijarnpreecha, Napat Leeaphorn, Patompong Ungprasert, Ankit Sakhuja, Franco H Cabeza Rivera, Wisit Cheungpasitporn. Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis. World Journal of Hepatology 2018; 10(2): 337-346 doi: 10.4254/wjh.v10.i2.337
|
3 |
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantation. Journal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
|
4 |
Sarah Schrauben, Jeffrey S. Berns. National Kidney Foundation' s Primer on Kidney Diseases. 2018; : 225 doi: 10.1016/B978-0-323-47794-9.00023-8
|
5 |
Giuseppe Coppolino, Mariadelina Simeoni, Chiara Summaria, Maria Concetta Postorino, Laura Rivoli, Alessio Strazzulla, Carlo Torti, Giorgio Fuiano. The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists. Journal of Nephrology 2015; 28(4): 393 doi: 10.1007/s40620-015-0214-0
|
6 |
C. Ng, R. Danguilan, G. Pamugas, E. Que. Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010. Transplantation Proceedings 2018; 50(10): 3242 doi: 10.1016/j.transproceed.2018.07.028
|
7 |
Apurva S. Shah, Deepak N. Amarapurkar. Spectrum of hepatitis B and renal involvement. Liver International 2018; 38(1): 23 doi: 10.1111/liv.13498
|
8 |
E. Durante‐Mangoni, M. Vitrone, A. Parrella, R. Andini, D. Iossa, E. Ragone, E. Falco, C. Maiello, R. Utili, R. Zampino. Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients. Transplant Infectious Disease 2016; 18(3): 319 doi: 10.1111/tid.12525
|
9 |
Massimiliano Veroux, Vincenzo Ardita, Daniela Corona, Alessia Giaquinta, Burcin Ekser, Nunziata Sinagra, Domenico Zerbo, Marco Patanè, Cecilia Gozzo, Pierfrancesco Veroux. Kidney Transplantation From Donors with Hepatitis B. Medical Science Monitor 2016; 22: 1427 doi: 10.12659/MSM.896048
|
10 |
Kevin Lu, Kun-Yuan Chiu. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplantation Proceedings 2023; 55(7): 1581 doi: 10.1016/j.transproceed.2023.05.017
|
11 |
Ezequiel Ridruejo. Antiviral treatment for chronic hepatitis B in renal transplant patients. World Journal of Hepatology 2015; 7(2): 189-203 doi: 10.4254/wjh.v7.i2.189
|
12 |
Mythili Ghanta, Belinda Jim. Renal Transplantation in Advanced Chronic Kidney Disease Patients. Medical Clinics of North America 2016; 100(3): 465 doi: 10.1016/j.mcna.2015.12.003
|
13 |
Kevin Lu, Kun-Yuan Chiu. Comparative Survival Analysis of Dialysis and Renal Transplantation in HBV-Infected End-Stage Renal Disease Patients. Transplantation Proceedings 2023; 55(10): 2429 doi: 10.1016/j.transproceed.2023.09.015
|
14 |
Sneha Haridas Anupama, Rajeevalochana Parthasarathy, Milly Mathew, Priya Haridas Anupama, Georgi Abraham. Rectal Carcinoma 27 Years' Postkidney Transplant in a Chronic Hepatitis B Patient - A Case Report. Indian Journal of Transplantation 2022; 16(1): 135 doi: 10.4103/ijot.ijot_128_20
|
15 |
Reynold I. Lopez‐Soler, Cara Joyce, Laura Cotiguala, Oswaldo Aguirre, Manpreet Samra, Chrsitine Trotter, Geraldine Zingraf, Jeffrey Sorensen, Rupinder Sodhi, Anne Thorndyke. Utilization of Hepatitis B viremic donors (NAT+) leads to improved kidney transplant access for older adult recipients with little to no wait time. Transplant Infectious Disease 2024; 26(3) doi: 10.1111/tid.14295
|
16 |
V.T. Yilmaz, İ. Aliosmanoglu, H. Erbis, B.V. Ulger, R. Cetinkaya, G. Suleymanlar, H. Kocak. Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(−) donors. Transplant Infectious Disease 2016; 18(1): 55 doi: 10.1111/tid.12482
|